---
title: "Studio LSD Ltd (STUDIOLSD) — Share Price, Financials & Analysis"
symbol: "STUDIOLSD"
company: "Studio LSD Ltd"
canonical: "https://tapetide.com/stocks/STUDIOLSD"
isin: "INE17VO01028"
nse_symbol: "STUDIOLSD"
sector: "Consumer Discretionary"
industry: "Entertainment"
market_cap_cr: 47.22
generated_at: "2026-09-13T20:35:03.375Z"
---

# Studio LSD Ltd (STUDIOLSD)

Canonical page: https://tapetide.com/stocks/STUDIOLSD

## Company

- **NSE Symbol:** STUDIOLSD
- **ISIN:** INE17VO01028
- **Sector:** Consumer Discretionary
- **Industry:** Entertainment
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2025-08-25
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** studiolsd.in

## About

Incorporated in 2017, Studio LSD Ltd is in the production and content creation for television, films, and new media; film distribution and exhibition through theatres, cinemas, studios, and shows.[1]

## Latest Price

- **Price:** ₹9.6
- **Change:** +0.25 (+2.67%)
- **Open:** ₹9.6
- **Day High:** ₹9.6
- **Day Low:** ₹9.6
- **Previous Close:** ₹9.35
- **Volume:** 10000
- **As Of:** 2026-09-11T09:59:47+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:14.809496Z.

- **Market Cap:** ₹47.22 Cr
- **Classification:** SME
- **P/E (reported):** -49.2
- **Book Value:** ₹15.27
- **Price to Book:** 0.61
- **Dividend Yield:** 0%
- **ROE:** -1.26%
- **ROCE:** -0.93%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹74.3 Cr
- **Net Income:** ₹-1 Cr
- **EBITDA:** ₹-0.3 Cr
- **52-Week High:** ₹27.95
- **52-Week Low:** ₹7.15
- **RSI (14):** 51.35

## Tapetide Score

- **Score:** 50 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Flat
- **Percentile:** 47.7 (of 4473 scored stocks)
- **Confidence:** 84%
- **Data coverage:** 67%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 77.6 | 9% |
| growth | 12.82 | 9% |
| momentum | 52.44 | 12% |
| ownership | 50 | 24% |
| quality | 67.46 | 22% |
| valuation | 40.71 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.63 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 23.8%

### Weaknesses

- Company has low interest coverage ratio.
- Debtor days have increased from 87.6 to 107 days.
- Working capital days have increased from 73.1 days to 164 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -489.67% | -393.54% | — |
| ebitda margin growth | -102.55% | -102.69% | -105.84% |
| net income growth | -108.47% | -109.17% | -20% |
| revenue growth | -29.24% | 16% | 68% |
| roce | -101.63% | -101.01% | 53.48% |
| roe | -102.95% | 36.73% | -103% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 62.53 | 41.95 | 39.27 | 32.84 |
| Expenses | 53.08 | 35.89 | 44.09 | 30.54 |
| Operating Profit | 9.45 | 6.06 | -4.82 | 2.3 |
| OPM % | 15.11 | 14.45 | -12.27 | 7 |
| Other Income | 0.21 | 0.32 | 1.05 | 1.17 |
| Interest | 0 | 0 | 0.02 | 0 |
| Depreciation | 0.12 | 0.15 | 0.1 | 0.35 |
| Profit before tax | 9.54 | 6.23 | -3.89 | 3.12 |
| Tax % | 26.31 | 24.08 | -10.28 | 20.19 |
| Net Profit | 7.03 | 4.74 | -3.49 | 2.49 |
| EPS in Rs | 14.61 | 1.16 | -0.67 | 0.48 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 46.89 | 5.42 | 14.61 | 46.68 | 102.48 | 104.48 | 72.11 |
| Expenses | 44.74 | 6.94 | 13.63 | 42.94 | 87.65 | 88.94 | 74.62 |
| Operating Profit | 2.15 | -1.52 | 0.98 | 3.74 | 14.83 | 15.54 | -2.51 |
| OPM % | 4.59 | -28.04 | 6.71 | 8.01 | 14.47 | 14.87 | -3.48 |
| Other Income | 0.01 | 0.39 | 0 | 0.04 | 0.02 | 0.5 | 2.22 |
| Interest | 0.64 | 0.07 | 0.04 | 0.1 | 0.01 | 0 | 0.03 |
| Depreciation | 0.06 | 0.05 | 0.03 | 0.04 | 0.18 | 0.27 | 0.45 |
| Profit before tax | 1.46 | -1.25 | 0.91 | 3.64 | 14.66 | 15.77 | -0.77 |
| Tax % | 26.03 | -0.8 | -1.1 | 23.08 | 25.65 | 25.43 | 29.87 |
| Net Profit | 1.09 | -1.24 | 0.91 | 2.79 | 10.9 | 11.77 | -1 |
| EPS in Rs | 1090 | -1240 | 910 | 2790 | 10900 | 2.88 | -0.19 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 8.18 | 10.38 |
| Reserves | 2.49 | 1.25 | 2.16 | 4.95 | 15.86 | 19.36 | 68.86 |
| Borrowings | 1.21 | 0.91 | 0.44 | 0.06 | 0 | 0 | 0 |
| Other Liabilities | 14.97 | 3.15 | 1.53 | 13.14 | 20.62 | 19.13 | 13.91 |
| Total Liabilities | 18.68 | 5.32 | 4.14 | 18.16 | 36.49 | 46.67 | 93.15 |
| Fixed Assets | 0.09 | 0.09 | 0.08 | 0.26 | 0.77 | 0.53 | 4.23 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2.27 |
| Investments | 0 | 0 | 0.01 | 0.01 | 1.7 | 11.02 | 7.4 |
| Other Assets | 18.59 | 5.23 | 4.05 | 17.89 | 34.02 | 35.12 | 79.25 |
| Total Assets | 18.68 | 5.32 | 4.14 | 18.16 | 36.49 | 46.67 | 93.15 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.49 | -2.05 | 0.55 | 1 | 7.58 | 5.71 | -22.25 |
| Cash from Investing Activity | -0.1 | -0.04 | -0.03 | -0.2 | -2.36 | -9.11 | -1.52 |
| Cash from Financing Activity | -0.34 | 0.15 | -0.5 | -0.48 | -0.07 | 0 | 52.67 |
| Net Cash Flow | 2.05 | -1.94 | 0.02 | 0.32 | 5.15 | -3.4 | 28.9 |
| Free Cash Flow | 2.39 | -2.09 | 0.53 | 0.78 | 6.9 | 5.65 | -28.67 |
| CFO/OP | 156 | 136 | 55 | 49 | 77 | 62 | 817 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 90.06 | 279.47 | 12.74 | 116.66 | 85.48 | 70.04 | 107.41 |
| Cash Conversion Cycle | 90.06 | 279.47 | 12.74 | 116.66 | 85.48 | 70.04 | 107.41 |
| Working Capital Days | -10.2 | 30.3 | 5.5 | 22.13 | 16.13 | 39.34 | 163.85 |
| ROCE % | — | -40.14 | 39.75 | 98.03 | 140.45 | 71.78 | -3.22 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Promoters | 73.5% | 73.5% | 73.5% | 73.5% |
| FIIs | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% |
| Public | 24% | 24.05% | 24.13% | 24.18% |
| Others | 2.5% | 2.45% | 2.37% | 2.32% |
| No. of Shareholders | 2779 | 2641 | 2475 | 2406 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 7 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 9.49 | Buy |
| EMA (10) | 9.47 | Buy |
| SMA (20) | 9.24 | Buy |
| EMA (20) | 9.34 | Buy |
| SMA (50) | 9.19 | Buy |
| EMA (50) | 9.37 | Buy |
| SMA (100) | 9.86 | Sell |
| EMA (100) | 9.99 | Sell |
| SMA (200) | 10.8 | Sell |
| EMA (200) | 12.2 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 55.92 | Neutral |
| MACD (12,26,9) | 0.13 | Buy |
| Stochastic (14,3,3) | 70.22 | Neutral |
| ADX (14) | 24.52 | Neutral |
| Williams %R (14) | -24.14 | Neutral |
| ATR (14) | 0.36 | High Volatility |
| ROC (12) | 6.08 | Buy |
| Stoch RSI (14) | 54.6 | Neutral |
| UO (7,14,28) | 69.56 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 April 2026 - Submitted share capital audit report for quarter ended March 31, 2026; no discrepancies reported. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 April 2026 - Submitted share capital audit report for quarter ended March 31, 2026; no discrepancies reported.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_09042026142225_Reg76.pdf) |
| 8 Sep - Board noted CFO resignation; appointed Parth Shah CFO; H1 FY26 loss ₹349.03 lakh. | [Outcome of Board Meeting 8 Sep - Board noted CFO resignation; appointed Parth Shah CFO; H1 FY26 loss ₹349.03 lakh.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_08092026215833_Outcome.pdf) |
| 6 March 2026 - Participated in Arihant Bharat Connect Rising Stars conference on March 6, 2026; no UPSI. | [Analysts/Institutional Investor Meet/Con. Call Updates 6 March 2026 - Participated in Arihant Bharat Connect Rising Stars conference on March 6, 2026; no UPSI.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_06032026154940_outcome.pdf) |
| 6 April 2026 - Studio LSD signed a production agreement with JioStar India on April 6, 2026 for a TV show. | [Updates 6 April 2026 - Studio LSD signed a production agreement with JioStar India on April 6, 2026 for a TV show.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_06042026191558_corpannountdsm.pdf) |
| 4 Aug - Studio LSD signed 10-year non-exclusive content catalogue licensing agreement with All About Content Limited. | [Agreements 4 Aug - Studio LSD signed 10-year non-exclusive content catalogue licensing agreement with All About Content Limited.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_04082026221248_NSE_Reg30_Disclosure_Music_Licencesing.pdf) |
| 4 Aug - Studio LSD signed 10-year content catalogue licensing agreement with All About Content Limited on August 4, 2026. | [Agreements 4 Aug - Studio LSD signed 10-year content catalogue licensing agreement with All About Content Limited on August 4, 2026.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_04082026222257_NSE_Reg30_Disclosure_Music_Licencesing.pdf) |
| 31 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after FY2026 results dissemination. | [Trading Window 31 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after FY2026 results dissemination.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_31032026191534_TW.pdf) |
| 3 February 2026 - Monitoring agency and auditor certify no deviation in utilization of INR53.90cr IPO proceeds for quarter ended 31-Dec-2025. | [Monitoring Agency Report 3 February 2026 - Monitoring agency and auditor certify no deviation in utilization of INR53.90cr IPO proceeds for quarter ended 31-Dec-2025.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_03022026193911_STAT_OF_DEVIATION.pdf) |
| 3 February 2026 - Board on 03-Feb-2026 approved monitoring report; INR53.90 crore IPO proceeds, INR26.35 crore unutilized; film retitled CONMAN→ASSI BAAGHI CHANGEY. | [Outcome of Board Meeting 3 February 2026 - Board on 03-Feb-2026 approved monitoring report; INR53.90 crore IPO proceeds, INR26.35 crore unutilized; film retitled CONMAN→ASSI BAAGHI CHANGEY.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_03022026193047_Outcome_of_BM.pdf) |
| 3 April 2026 - Submitted Regulation 13(3) investor complaints certificate for quarter ended 31 March 2026. | [Integrated Filing- Governance 3 April 2026 - Submitted Regulation 13(3) investor complaints certificate for quarter ended 31 March 2026.](https://nsearchives.nseindia.com/corporate/STUDIOLSD2017_03042026190735_Reg13.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28397_STUDIOLSD_2024_2025_A_7051378_04092025131705.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:35:03.375Z.